相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-α for advanced hepatocellular carcinoma with extrahepatic metastasis
Masato Nakamura et al.
CANCER (2008)
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
W. Song et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Cancer Initiating Cells or Cancer Stem Cells in the Gastrointestinal Tract and Liver
Gang-Ming Zou
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases
Kiminori Uka et al.
ONCOLOGY (2008)
Combination Therapy with S-1 and Pegylated Interferon Alpha for Advanced Hepatocellular Carcinoma
Kazuomi Ueshima et al.
ONCOLOGY (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Combination therapy with PEG-IFN-α and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53
S. Hagiwara et al.
BRITISH JOURNAL OF CANCER (2007)
Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells
Shinji Oie et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Atsushi Suetsugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Natural history of compensated cirrhosis in the Child-Pugh Class A compared between 490 patients with hepatitis C and 167 with B virus infections
M Kobayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil;: role of type I interferon receptor expression
H Ota et al.
BRITISH JOURNAL OF CANCER (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Alteration in copy numbers of genes as a mechanism for acquired drug resistance
K Yasui et al.
CANCER RESEARCH (2004)
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-α/5-fluorouracil against hepatocellular carcinoma
T Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction
Y Shintani et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Preferential induction of apoptosis for primary human leukemic stem cells
ML Guzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Combined Intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
M Sakon et al.
CANCER (2002)
分享论文
